Literature DB >> 19713357

Fatty acid hydroperoxides support cytochrome P450 2S1-mediated bioactivation of benzo[a]pyrene-7,8-dihydrodiol.

Peter H Bui1, Erin L Hsu, Oliver Hankinson.   

Abstract

In the accompanying report (p. 1031), we showed that a novel dioxin-inducible cytochrome P450, CYP2S1, efficiently metabolizes benzo[a]pyrene-trans-7,8-dihydrodiol (BaP-7,8-diol) into the highly mutagenic and carcinogenic benzo[a]pyrene-r-7,t-8-dihydrodiol-t-9,10-epoxide (BaP-diol-t-epoxide), using cumene hydroperoxide in lieu of NADPH/O(2). Lipid hydroperoxide-supported P450 oxidation has been reported in several cases. However, it has not yet been described for the bioactivation of BaP-7,8-diol. In this report, we demonstrate that CYP2S1 can use various fatty acid hydroperoxides to support epoxidation of BaP-7,8-diol at a much higher rate than with cumene hydroperoxide. Kinetic analyses with several fatty acid hydroperoxides revealed that 13S-hydroperoxy-9Z,11E-octadecadienoic acid (13-HpODE) was the most potent oxidant tested (K(m), 3.4 +/- 0.8 microM; turnover, 4.51 +/- 0.13 min(-1)), followed by 12S-hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (K(m), 2.8 +/- 0.7 microM; turnover, 3.7 +/- 0.1 min(-1)), 5S-hydroperoxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (K(m), 2.7 +/- 0.8 microM; turnover, 3.69 +/- 0.09 min(-1)), and 15S-hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoic acid (K(m), 11.6 +/- 0.3 microM; turnover, 0.578 +/- 0.030 min(-1)). The antioxidant butylated hydroxyanisole inhibited CYP2S1-catalyzed epoxidation by 100%, suggesting that epoxidation proceeds by a free radical mechanism. Other cytochromes P450, including CYP1A1, CYP1B1, CYP1A2, and CYP3A4, were also able to epoxidize BaP-7,8-diol using various fatty acid hydroperoxides, although at slower rates than CYP2S1. The cytotoxicity of BaP-7,8-diol significantly increased in mammalian cells overexpressing CYP2S1, and BaP-diol-t-epoxide formation in these cells also increased in the presence of 13-HpODE. Together, these results suggest that fatty acid hydroperoxides can serve as physiological cofactors in supporting in vivo CYP2S1-catalyzed oxidation of BaP-7,8-diol, and that fatty acid hydroperoxides and CYP2S1 may play important roles in benzo[a]pyrene-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713357      PMCID: PMC2774993          DOI: 10.1124/mol.109.057760

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  41 in total

Review 1.  Structure-function features of flaxseed allene oxide synthase.

Authors:  A R Brash; W C Song
Journal:  J Lipid Mediat Cell Signal       Date:  1995-10

2.  Contribution of human cytochrome P450 to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol metabolism, as predicted from heterologous expression in yeast.

Authors:  J C Gautier; S Lecoeur; J Cosme; A Perret; P Urban; P Beaune; D Pompon
Journal:  Pharmacogenetics       Date:  1996-12

3.  Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase.

Authors:  J Schulze; K Tschöp; M Lehnerer; P Hlavica
Journal:  Biochem Biophys Res Commun       Date:  2000-04-21       Impact factor: 3.575

4.  Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples.

Authors:  J L McLemore; P Beeley; K Thorton; K Morrisroe; W Blackwell; A Dasgupta
Journal:  Am J Clin Pathol       Date:  1998-03       Impact factor: 2.493

5.  Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes.

Authors:  M R Anari; S Khan; S D Jatoe; P J O'Brien
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

6.  Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin.

Authors:  C Mahle; A Dasgupta
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase.

Authors:  C L Crespi; V P Miller
Journal:  Pharmacogenetics       Date:  1997-06

8.  Microsomal cytochrome P450 peroxygenase metabolism of arachidonic acid in guinea pig liver.

Authors:  G P McCallum; A C Weedon; P Krug; J R Bend
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

9.  Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

Authors:  K E Thummel; D O'Shea; M F Paine; D D Shen; K L Kunze; J D Perkins; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1996-05       Impact factor: 6.875

10.  Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.

Authors:  T J Smith; G D Stoner; C S Yang
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

View more
  22 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 2.  Characterizing proteins of unknown function: orphan cytochrome p450 enzymes as a paradigm.

Authors:  F Peter Guengerich; Zhongmei Tang; S Giovanna Salamanca-Pinzón; Qian Cheng
Journal:  Mol Interv       Date:  2010-06

Review 3.  The role of antioxidants and pro-oxidants in colon cancer.

Authors:  William L Stone; Koyamangalath Krishnan; Sharon E Campbell; Victoria E Palau
Journal:  World J Gastrointest Oncol       Date:  2014-03-15

Review 4.  Formation and Cleavage of C-C Bonds by Enzymatic Oxidation-Reduction Reactions.

Authors:  F Peter Guengerich; Francis K Yoshimoto
Journal:  Chem Rev       Date:  2018-06-22       Impact factor: 60.622

Review 5.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

Review 6.  Orphans in the human cytochrome P450 superfamily: approaches to discovering functions and relevance in pharmacology.

Authors:  F Peter Guengerich; Qian Cheng
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

7.  Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.

Authors:  Yuan Wei; Lei Li; Xin Zhou; Qing-Yu Zhang; Anwar Dunbar; Fang Liu; Kerri Kluetzman; Weizhu Yang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-10-16       Impact factor: 3.922

8.  Functional characterization of human cytochrome P450 2S1 using a synthetic gene-expressed protein in Escherichia coli.

Authors:  Peter H Bui; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2009-08-27       Impact factor: 4.436

9.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

Review 10.  Cytochromes p450 and skin cancer: role of local endocrine pathways.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Igor Semak; Blazej Zbytek; Alexander Pisarchik; Wei Li; Jordan Zjawiony; Robert C Tuckey
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.